InvestorsHub Logo
Followers 26
Posts 5775
Boards Moderated 1
Alias Born 08/09/2000

Re: None

Wednesday, 03/17/2010 9:33:56 AM

Wednesday, March 17, 2010 9:33:56 AM

Post# of 30565
NEWS --

DANVILLE, CA, Mar 17, 2010 (MARKETWIRE via COMTEX) -- S3 Investment Company,
Inc. (PINKSHEETS: SIVC) today announced that Chairman and CEO Jim Bickel has
traveled to China to attend an investment conference and provide support for the
company's Redwood subsidiaries operating in the China market.

While on his trip, Mr. Bickel attended the Rodman & Renshaw Annual Investment
Conference held March 7-9 in Beijing, where 130 companies were scheduled to
present and the speakers included former U.S. President Bill Clinton (via
satellite) and Keynote Speaker former U.S. Secretary of State Colin Powell.
Attendees included institutional investors, venture capitalists, sophisticated
private investors, industry executives, business development executives and
private equity firms. Mr. Bickel attended the conference on behalf of S3's
wholly owned Redwood Capital subsidiary, which assists private Chinese companies
in accessing the North American capital markets through reverse merger and/or
financing transactions.

Mr. Bickel is also working with Redwood Capital ma nagement and staff on the
company's recently announced new client, which operates in China's rapidly
growing cattle industry. The client is engaged in the research, development and
production of cattle and beef products in China, and the client's goal is to
become the country's leading brand of premium cattle and beef products.

During the trip, Mr. Bickel is also participating in interviews with several
potential Redwood Capital client companies in order to further bolster the
company's pipeline of new deals. The companies are being interviewed as part of
the screening and due diligence processes, and as a result of the meetings, at
least one new client is expected to be signed while Mr. Bickel is in China.

"This trip has gone very well so far, including our attendance at the Rodman &
Renshaw conference and our interviews with new and potential Redwood Capital
clients," said Mr. Bickel. "Face-to-face meetings are the most effective way to
prepare clients for the close of their transactions, as well as to properly
screen potential clients as part of our due diligence process. We look forward
to reporting any material progress that is achieved as a result of these
meetings, including the signing of any new clients."

To sign up to receive information by email directly from S3 Investment Company
when new press releases, investor newsletters, SEC filings or other information
is disclosed, please visit http://www.s3investments.com/investors/.

About S3 Investment Company, Inc. S3 Investment Company, Inc.
(http://www.s3investments.com) and its Redwood Group International subsidiary
are focused on facilitating the success of two subsidiaries operating in the
China market. Redwood Capital, Inc. assists private Chinese companies in
accessing the North American capital markets by utilizing a network of
investment banking relationships to achieve reverse merger transa ctions. For
more information, please visit http://www.redwoodcapinc.com. Redwood Medical,
Inc. assists companies seeking to import and distribute Western medical
technologies and products into the China market.

Any statements contained herein related to future events are forward-looking
statements and are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Readers are cautioned not to place
undue reliance on forward-looking statements. S3 Investment Company, Inc.
undertakes no obligation to update any such statements to reflect actual events.





Contacts

For S3 Investment Company

Gemini Financial Communications, Inc.

951-200-4107

Email Contact





SOURCE: S3 Investment Company




CONTACT: http://www2.marketwire.com/mw/emailprcntct?id=9EA38D5A04A455FA




Copyright 2010 Marketwire, Inc., All rights reserved.

-0-




SUBJECT CODE: Financial Services:Commercial and Investment Banking

Pharmaceuticals and Biotech:Equipment and Supplies

Medical and Healthcare:Healthcare

Financial Services:Venture Capital